Related references
Note: Only part of the references are listed.A PML/RARα direct target atlas redefines transcriptional deregulation in acute promyelocytic leukemia
Yun Tan et al.
BLOOD (2021)
Arsenic trioxide replacing or reducing chemotherapy in consolidation therapy for acute promyelocytic leukemia (APL2012 trial)
Li Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism
Luca Mazzarella et al.
HAEMATOLOGICA (2020)
Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer
Marteinn Thor Snaebjornsson et al.
CELL METABOLISM (2020)
An effective early death scoring system for predicting early death risk in de novo acute promyelocytic leukemia
Ping Cai et al.
LEUKEMIA & LYMPHOMA (2020)
JNK-mediated disruption of bile acid homeostasis promotes intrahepatic cholangiocarcinoma
Elisa Manieri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Hypertriglyceridemia in Newly Diagnosed Acute Promyelocytic Leukemia
Jianai Sun et al.
FRONTIERS IN ONCOLOGY (2020)
PML-RARα interaction with TRIB3 impedes PPARγ/RXR function and triggers dyslipidemia in acute promyelocytic leukemia
Ke Li et al.
THERANOSTICS (2020)
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet
Miguel A. Sanz et al.
BLOOD (2019)
FLT3-ITD impedes retinoic acid, but not arsenic, responses in murine acute promyelocytic leukemias
Cecile Esnault et al.
BLOOD (2019)
The global problem of early deaths in acute promyelocytic leukemia: A strategy to decrease induction mortality in the most curable leukemia
A. P. Jillella et al.
BLOOD REVIEWS (2018)
Molecular remission as a therapeutic objective in acute promyelocytic leukemia
Laura Cicconi et al.
LEUKEMIA (2018)
Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein Interaction
Han Han et al.
MOLECULAR CELL (2018)
Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure
Hugues de The et al.
CANCER CELL (2017)
Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer
Qiuping Liu et al.
CANCER LETTERS (2017)
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
Simon Mantha et al.
BLOOD (2017)
Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trials
Jorge J. Castillo et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Self-renewal of a purified Tie2+ hematopoietic stem cell population relies on mitochondrial clearance
Kyoko Ito et al.
SCIENCE (2016)
Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points
Lisa J. Martin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial
Alan K. Burnett et al.
LANCET ONCOLOGY (2015)
Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points
Lisa J. Martin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults
Krishnan Bhaskaran et al.
LANCET (2014)
Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications - a review
Bogna Grygiel-Gorniak
NUTRITION JOURNAL (2014)
The Association of Serum Lipids With Colorectal Adenomas
Moon Hee Yang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Cellular Fatty Acid Metabolism and Cancer
Erin Currie et al.
CELL METABOLISM (2013)
How cancer metabolism is tuned for proliferation and vulnerable to disruption
Almut Schulze et al.
NATURE (2012)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
Cholesterol esters as growth regulators of lymphocytic leukaemia cells
M. F. Mulas et al.
CELL PROLIFERATION (2011)
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry
S. Lehmann et al.
LEUKEMIA (2011)
Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis
Daniel K. Nomura et al.
CELL (2010)
Acute promyelocytic leukaemia: novel insights into the mechanisms of cure
Hugues de The et al.
NATURE REVIEWS CANCER (2010)
Structural and Functional Alterations of FLT3 in Acute Myeloid Leukemia
Soheil Meshinchi et al.
CLINICAL CANCER RESEARCH (2009)
CBL Exon 8/9 Mutants Activate the FLT3 Pathway and Cluster in Core Binding Factor/11q Deletion Acute Myeloid Leukemia/Myelodysplastic Syndrome Subtypes
Carola Reindl et al.
CLINICAL CANCER RESEARCH (2009)
Body Mass Index and Risk, Age of Onset, and Survival in Patients With Pancreatic Cancer
Donghui Li et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice
Elizabeth E. Girroir et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
The Flt3 receptor tyrosine kinase collaborates with NUP98-HOX fusions in acute myeloid leukemia
Lars Palmqvist et al.
BLOOD (2006)
Peroxisome-proliferator-activated receptors and cancers: Complex stories
L Michalik et al.
NATURE REVIEWS CANCER (2004)
A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657
J Sohal et al.
BLOOD (2003)
Peroxisome proliferator-activated receptor α in the human breast cancer cell lines MCF-7 and MDA-MB-231
KM Suchanek et al.
MOLECULAR CARCINOGENESIS (2002)
PML/RARα and FLT3-ITD induce an APL-like disease in a mouse model
LM Kelly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Peroxisome proliferator-activated receptor α activators improve insulin sensitivity and reduce adiposity
M Guerre-Millo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Roles of PPARs in health and disease
S Kersten et al.
NATURE (2000)
The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only one rate limiting mutation
M Vickers et al.
LEUKEMIA (2000)
Share Paper
